Bausch Health Companies Inc (BHC) NPV
Sell:$7.26Buy:$7.27
$0.04
(0.48%)
- This stock can be held in a
Stocks and Shares ISA$0.04
(0.48%)$0.04
(0.48%)Company Information
About this company
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
Key people
Key facts
- EPIC-
- LocationCanada
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINCA0717341071
- Market cap$2.69bn
- Employees20,270
- Shares in issue361.63m
- ExchangeToronto Stock Exchange
- IndexToronto SE 300 Composite Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.